Poor survival after heart attack linked to excess levels of signaling protein in heart

(Temple University Health System) Heart failure is one form of heart disease, for which new therapies are desperately needed. Now, in new work, scientists at the Lewis Katz School of Medicine at Temple University identify a path to a promising novel therapeutic strategy, taking aim at a molecule in the heart known as G protein-coupled receptor kinase 5 (GRK5).